Pharmesis International Ltd. provided earnings guidance for the first quarter ended March 31, 2019. The board of directors of the company announced that after preliminary assessment of the group's unaudited financial results, the Board would like to inform the shareholders and investors that the group is expected to report a net loss for the unaudited financial results for the first quarter ended 31 March 2019 as compared to a net profit for the corresponding period for the first quarter ended 31 March 2018. The expected net loss was mainly attributed to absence of other income and lower revenue in first quarter of 2019 as compared to first quarter of 2018.